you MI Barber Shop Owner Defies Gov. Whitmer Shutdown Order…Opens Business…Police Officer Walks In…Says, “I love you!”…Walks Out By 100percentfedup.com Published On :: Wed, 06 May 2020 01:49:01 +0000 The following article, MI Barber Shop Owner Defies Gov. Whitmer Shutdown Order…Opens Business…Police Officer Walks In…Says, “I love you!”…Walks Out, was first published on 100PercentFedUp.com. Last week, we reported about how Shelley Luther, owner of the Salon Á La Mode in North Dallas, Texas, who opened up her business in defiance of lockdown orders in the city. The salon owner said that she was ignoring a citation and a cease and desist order from the city to shut down. This one […] Continue reading: MI Barber Shop Owner Defies Gov. Whitmer Shutdown Order…Opens Business…Police Officer Walks In…Says, “I love you!”…Walks Out ... Full Article Featured Politics
you Coronavirus Vaccine: Available For All, or When it's Your Turn? By feedproxy.google.com Published On :: Mon, 04 May 2020 15:39:19 +0000 4 May 2020 Professor David Salisbury CB Associate Fellow, Global Health Programme LinkedIn Despite high-level commitments and pledges to cooperate to ensure equitable global access to a coronavirus vaccine, prospects for fair distribution are uncertain. 2020-05-04-Vaccine-COVID-Brazil Researcher in Brazil working on virus replication in order to develop a vaccine against the coronavirus. Photo by DOUGLAS MAGNO/AFP via Getty Images. When the H1N1 influenza pandemic struck in 2009, some industrialized countries were well prepared. Many countries’ preparedness plans had focused on preparing for an influenza pandemic and based on earlier alerts over the H5N1 ‘bird flu’ virus, countries had made advanced purchase or ‘sleeping’ contracts for vaccine supplies that could be activated as soon as a pandemic was declared. Countries without contracts scrambled to get supplies after those that already had contracts received their vaccine.Following the 2009 pandemic, the European Union (EU) developed plans for joint-purchase vaccine contracts that any member state could join, guaranteeing the same price per dose for everyone. In 2009, low-income countries were unable to get the vaccine until manufacturers agreed to let 10 per cent of their production go to the World Health Organization (WHO).The situation for COVID-19 could be even worse. No country had a sleeping contract in place for a COVID-19 vaccine since nobody had anticipated that the next pandemic would be a coronavirus, not an influenza virus. With around 80 candidate vaccines reported to be in development, choosing the right one will be like playing roulette.These candidates will be whittled down as some will fail at an early stage of development and others will not get to scale-up for manufacturing. All of the world’s major vaccine pharmaceutical companies have said that they will divert resources to manufacture COVID-19 vaccines and, as long as they choose the right candidate for production, they have the expertise and the capacity to produce in huge quantities.From roulette to a horse raceOur game now changes from roulette to a horse race, as the probability of winning is a matter of odds not a random chance. Countries are now able to try to make contracts alone or in purchasing consortia with other states, and with one of the major companies or with multiple companies. This would be like betting on one of the favourites.For example, it has been reported that Oxford University has made an agreement with pharmaceutical company AstraZeneca, with a possibility of 100 million doses being available by the end of 2020. If the vaccine works and those doses materialize, and are all available for the UK, then the UK population requirements will be met in full, and the challenge becomes vaccinating everyone as quickly as possible.Even if half of the doses were reserved for the UK, all those in high-risk or occupational groups could be vaccinated rapidly. However, as each major manufacturer accepts more contracts, the quantity that each country will get diminishes and the time to vaccinate the at-risk population gets longer.At this point, it is not known how manufacturers will respond to requests for vaccine and how they will apportion supplies between different markets. You could bet on an outsider. You study the field and select a biotech that has potential with a good production development programme and a tie-in with a smaller-scale production facility.If other countries do not try to get contracts, you will get your vaccine as fast as manufacturing can be scaled up; but because it is a small manufacturer, your supplies may take a long time. And outsiders do not often win races. You can of course, depending on your resources, cover several runners and try to make multiple contracts. However, you take on the risk that some will fail, and you may have compromised your eventual supply.On April 24, the WHO co-hosted a meeting with the president of France, the president of the European Commission and the Bill & Melinda Gates Foundation. It brought together heads of state and industry leaders who committed to ‘work towards equitable global access based on an unprecedented level of partnership’. They agreed ‘to create a strong unified voice, to build on past experience and to be accountable to the world, to communities and to one another’ for vaccines, testing materials and treatments.They did not, however, say how this will be achieved and the absence of the United States was notable. The EU and its partners are hosting an international pledging conference on May 4 that aims to raise €7.5 billion in initial funding to kick-start global cooperation on vaccines. Co-hosts will be France, Germany, Italy, the United Kingdom, Norway and Saudi Arabia and the priorities will be ‘Test, Treat and Prevent’, with the latter dedicated to vaccines.Despite these expressions of altruism, every government will face the tension between wanting to protect their own populations as quickly as possible and knowing that this will disadvantage poorer countries, where health services are even less able to cope. It will not be a vote winner to offer a share in available vaccine to less-privileged countries.The factories for the biggest vaccine manufacturers are in Europe, the US and India. Will European manufacturers be obliged by the EU to restrict sales first to European countries? Will the US invoke its Defense Production Act and block vaccine exports until there are stocks enough for every American? And will vaccine only be available in India for those who can afford it?The lessons on vaccine availability from the 2009 influenza pandemic are clear: vaccine was not shared on anything like an equitable basis. It remains to be seen if we will do any better in 2020. Full Article
you Wish you were here: Meetings, no meetings, meeting reports [Editorial] By feedproxy.google.com Published On :: 2020-04-17T00:06:05-07:00 We've all been saying it: These are unprecedented times. The impacts of the COVID-19 pandemic are incredibly wide-ranging and affect all facets of life. One that is hitting the scientific community very hard is the cancellation of meetings, large and small. While we are well-versed in connecting with colleagues and collaborators across a variety of online platforms, these do not replace the immensely gratifying aspects of attending meetings in person: the pleasure of catching up with old friends and making new ones, the insights gained from having real-time conversations with others working on the same topic but with different expertise and perspectives, and the stimulating new scientific ideas we carry home. We have all been feeling the disappointment as we learn that one meeting after another is forced to cancel, from the vibrant ASBMB annual meeting to summer conferences of all types.Another loss from the appropriate but painful decision to cancel the ASBMB annual meeting was the chance to hear from our Herbert Tabor Early Career Investigator Awardees, who represent the best science published in JBC in the preceding year. This year, the competition was particularly fierce. We hope and anticipate that we will be able to hear from the winners at next year's ASBMB annual meeting. But in the meantime, we want to raise a toast to Wenchao Zhao, Yue Yang, Manisha Dagar, Febin Varghese, and Ayumi Nagashima-Kasahara as our 2020 winners. We've captured their award-winning 2019 papers (1–5) on the JBC website (6), and extended profiles of the... Full Article
you Pace Your Prose — Three Thoughts on Timing By mythicscribes.com Published On :: Sun, 02 Feb 2020 03:11:21 +0000 Have you ever come across a section of a book where it felt like everything happened at breakneck speed, and you could only just barely read fast enough to keep up? Or have you seen the opposite, where it’s all nice and slow and mellow, and where you’re able to really take your time and enjoy the beauty of the words? That’s the kind of thing I’ll be musing on today. Prose and pacing. Time and reading. Do note, this is not about how to pace your story, that’s an entirely different topic. The Basics Most writers will at one point or another have heard that a full stop is a signal for the reader to breathe. The shorter the sentences are, the quicker the breathing becomes, like when you’re excited. With longer sentences, the breaths grow longer, and deeper, and you calm down. And when you write really long sentences and don’t include any commas or other forms of punctuation your reader might just run out of breath and begin to feel a little panicked. There’s no ideal sentence length to strive for – rather the opposite. Continue reading Pace Your Prose — Three Thoughts on Timing at Mythic Scribes. Full Article Writing Craft & Technique
you History for Fantasy Writers: Do You Have a Moment? By mythicscribes.com Published On :: Sun, 16 Feb 2020 20:35:37 +0000 This is the second part of a two-part article on how time was perceived and measured in ancient and medieval Europe. In the last installment of History for Fantasy Writers I addressed years, months, weeks, and days. Now I turn to shorter lengths: days, hours and still shorter periods. I’ll close with a more general consideration of time and the awareness of time. Hours We carve the day into twenty-four hours, but in the past the hour was a malleable thing. There were twelve hours of daylight and twelve hours of night, regardless of the season. The day began with zero at sunrise. Then came the first hour, the second, and so on. The twelfth hour fell at sunset. A winter daylight hour was therefore shorter than a summer hour. This feels a little nuts at first, but it’s actually pretty sensible. At least the word midnight makes sense in that system—it’s the mid-point of the night, regardless of how long is the night. All we have to do is abandon the notion that an hour is a unit of time, to consider it as marking portions of a day. Continue reading History for Fantasy Writers: Do You Have a Moment? at Mythic Scribes. Full Article History history for fantasy writers how time was perceived and measured
you Make It Awesome — Three Tips for Impressing Your Readers By mythicscribes.com Published On :: Mon, 04 May 2020 20:35:47 +0000 You’re a fantasy writer. You’ve created an amazing and original world, full of wondrous magic, mind-blowing monsters, and fascinating new cultures. You’ve got powerful heroes, menacing villains, and mysterious mentors. There’s just the right amount of romance. In short, you’ve got all that good stuff you’d expect to find in a fantasy novel. Only, somehow it’s still not coming out quite as awe-inspiring as you’d envisioned it. Today, I’ve got three tips for you on how to make your awesome stuff seem more awesome. Establish the Norm “When everything is awesome, awesome becomes average.” Every now and then, I come across a book that begins with the writer very obviously trying to impress me with how cool their main character is, and what an amazing world they have created, and how scary the villain is. All at once. In the first chapter. It rarely works. Let’s say there’s a ballroom full of ultra-rich and mega-powerful vampires, and then someone flies in on a golden unicorn and starts shooting fireballs the shape of grinning skulls. That would probably look rather spectacular as an introduction to a movie, but does it work in a book? Continue reading Make It Awesome — Three Tips for Impressing Your Readers at Mythic Scribes. Full Article Writing Craft & Technique
you Human Rights: Right for You, Right for Us? By feedproxy.google.com Published On :: Mon, 04 May 2020 08:54:20 +0000 1 October 2007 , Number 5 Internationally, Britain has traded for decades on its human rights laurels. Its key role in building the successful European human rights system has long been celebrated, and human rights promotion remains a cornerstone of foreign and development policy. Domestically, the contrast could not be stronger. Newspapers are actively campaigning to ‘axe’ the Human Rights Act, and mainstream political leaders are joining in, hoping for electoral gains. Does this mean the British people have turned their backs on human rights? Sonya Sceats Associate Fellow, International Law Programme @SonyaSceats GettyImages-71296579.jpg The leader of Britain's Conservative Party, David Cameron Full Article
you Coronavirus Vaccine: Available For All, or When it's Your Turn? By feedproxy.google.com Published On :: Mon, 04 May 2020 15:39:19 +0000 4 May 2020 Professor David Salisbury CB Associate Fellow, Global Health Programme LinkedIn Despite high-level commitments and pledges to cooperate to ensure equitable global access to a coronavirus vaccine, prospects for fair distribution are uncertain. 2020-05-04-Vaccine-COVID-Brazil Researcher in Brazil working on virus replication in order to develop a vaccine against the coronavirus. Photo by DOUGLAS MAGNO/AFP via Getty Images. When the H1N1 influenza pandemic struck in 2009, some industrialized countries were well prepared. Many countries’ preparedness plans had focused on preparing for an influenza pandemic and based on earlier alerts over the H5N1 ‘bird flu’ virus, countries had made advanced purchase or ‘sleeping’ contracts for vaccine supplies that could be activated as soon as a pandemic was declared. Countries without contracts scrambled to get supplies after those that already had contracts received their vaccine.Following the 2009 pandemic, the European Union (EU) developed plans for joint-purchase vaccine contracts that any member state could join, guaranteeing the same price per dose for everyone. In 2009, low-income countries were unable to get the vaccine until manufacturers agreed to let 10 per cent of their production go to the World Health Organization (WHO).The situation for COVID-19 could be even worse. No country had a sleeping contract in place for a COVID-19 vaccine since nobody had anticipated that the next pandemic would be a coronavirus, not an influenza virus. With around 80 candidate vaccines reported to be in development, choosing the right one will be like playing roulette.These candidates will be whittled down as some will fail at an early stage of development and others will not get to scale-up for manufacturing. All of the world’s major vaccine pharmaceutical companies have said that they will divert resources to manufacture COVID-19 vaccines and, as long as they choose the right candidate for production, they have the expertise and the capacity to produce in huge quantities.From roulette to a horse raceOur game now changes from roulette to a horse race, as the probability of winning is a matter of odds not a random chance. Countries are now able to try to make contracts alone or in purchasing consortia with other states, and with one of the major companies or with multiple companies. This would be like betting on one of the favourites.For example, it has been reported that Oxford University has made an agreement with pharmaceutical company AstraZeneca, with a possibility of 100 million doses being available by the end of 2020. If the vaccine works and those doses materialize, and are all available for the UK, then the UK population requirements will be met in full, and the challenge becomes vaccinating everyone as quickly as possible.Even if half of the doses were reserved for the UK, all those in high-risk or occupational groups could be vaccinated rapidly. However, as each major manufacturer accepts more contracts, the quantity that each country will get diminishes and the time to vaccinate the at-risk population gets longer.At this point, it is not known how manufacturers will respond to requests for vaccine and how they will apportion supplies between different markets. You could bet on an outsider. You study the field and select a biotech that has potential with a good production development programme and a tie-in with a smaller-scale production facility.If other countries do not try to get contracts, you will get your vaccine as fast as manufacturing can be scaled up; but because it is a small manufacturer, your supplies may take a long time. And outsiders do not often win races. You can of course, depending on your resources, cover several runners and try to make multiple contracts. However, you take on the risk that some will fail, and you may have compromised your eventual supply.On April 24, the WHO co-hosted a meeting with the president of France, the president of the European Commission and the Bill & Melinda Gates Foundation. It brought together heads of state and industry leaders who committed to ‘work towards equitable global access based on an unprecedented level of partnership’. They agreed ‘to create a strong unified voice, to build on past experience and to be accountable to the world, to communities and to one another’ for vaccines, testing materials and treatments.They did not, however, say how this will be achieved and the absence of the United States was notable. The EU and its partners are hosting an international pledging conference on May 4 that aims to raise €7.5 billion in initial funding to kick-start global cooperation on vaccines. Co-hosts will be France, Germany, Italy, the United Kingdom, Norway and Saudi Arabia and the priorities will be ‘Test, Treat and Prevent’, with the latter dedicated to vaccines.Despite these expressions of altruism, every government will face the tension between wanting to protect their own populations as quickly as possible and knowing that this will disadvantage poorer countries, where health services are even less able to cope. It will not be a vote winner to offer a share in available vaccine to less-privileged countries.The factories for the biggest vaccine manufacturers are in Europe, the US and India. Will European manufacturers be obliged by the EU to restrict sales first to European countries? Will the US invoke its Defense Production Act and block vaccine exports until there are stocks enough for every American? And will vaccine only be available in India for those who can afford it?The lessons on vaccine availability from the 2009 influenza pandemic are clear: vaccine was not shared on anything like an equitable basis. It remains to be seen if we will do any better in 2020. Full Article
you Rethinking youth bulge theory in policy and scholarship: incorporating critical gender analysis By feedproxy.google.com Published On :: Thu, 07 May 2020 09:26:03 +0000 7 May 2020 , Volume 96, Number 3 Lesley Pruitt Read online For decades ‘youth bulge’ theory has dominated understandings of youth in mainstream International Relations. Youth bulge theory has also become part of some public media analyses, mainstream political rhetoric, and even officially enshrined in the foreign policy of some states. Through the ‘youth bulge’ lens, youth—especially males—have been presented as current or future perpetrators of violence. However, this article argues that the youth bulge thesis postulated in mainstream IR is based on flawed theoretical assumptions. In particular, supporters of youth bulge theory fail to engage with existing research by feminist IR scholars and thus take on a biological essentialist approach. This has led to theoretical and practical misunderstandings of the roles youth play in relation to conflict, peace and security. These partial and biased understandings have also resulted in less effective policy-making. In critically reflecting on the ‘youth bulge’ thesis, this article argues that applying gender analysis is crucial to understanding the involvement of young people in general—and young men in particular—in conflict. Doing so will contribute to advancing more accurate analysis in scholarship and policy-making. Full Article
you Planning for Africa's Future: Youth Perspectives from Kenya and South Africa By feedproxy.google.com Published On :: Wed, 25 Apr 2018 00:00:00 +0100 Full Article
you Our Shared Humanity: Governance, Youth and Leadership By feedproxy.google.com Published On :: Tue, 04 Jun 2019 00:00:00 +0100 Full Article
you The 2019 Arab Youth Survey: Pragmatism, Frustration and Optimism By feedproxy.google.com Published On :: Mon, 23 Sep 2019 00:00:00 +0100 Full Article
you Young and Male: Identity and Politics in Saudi Arabia By feedproxy.google.com Published On :: Fri, 29 Nov 2019 00:00:00 +0000 Full Article
you Undercurrents: Episode 45 - Politics in Kazakhstan, and Youth Engagement in Politics By feedproxy.google.com Published On :: Mon, 10 Feb 2020 00:00:00 +0000 Full Article
you Coronavirus Vaccine: Available For All, or When it's Your Turn? By feedproxy.google.com Published On :: Mon, 04 May 2020 15:39:19 +0000 4 May 2020 Professor David Salisbury CB Associate Fellow, Global Health Programme LinkedIn Despite high-level commitments and pledges to cooperate to ensure equitable global access to a coronavirus vaccine, prospects for fair distribution are uncertain. 2020-05-04-Vaccine-COVID-Brazil Researcher in Brazil working on virus replication in order to develop a vaccine against the coronavirus. Photo by DOUGLAS MAGNO/AFP via Getty Images. When the H1N1 influenza pandemic struck in 2009, some industrialized countries were well prepared. Many countries’ preparedness plans had focused on preparing for an influenza pandemic and based on earlier alerts over the H5N1 ‘bird flu’ virus, countries had made advanced purchase or ‘sleeping’ contracts for vaccine supplies that could be activated as soon as a pandemic was declared. Countries without contracts scrambled to get supplies after those that already had contracts received their vaccine.Following the 2009 pandemic, the European Union (EU) developed plans for joint-purchase vaccine contracts that any member state could join, guaranteeing the same price per dose for everyone. In 2009, low-income countries were unable to get the vaccine until manufacturers agreed to let 10 per cent of their production go to the World Health Organization (WHO).The situation for COVID-19 could be even worse. No country had a sleeping contract in place for a COVID-19 vaccine since nobody had anticipated that the next pandemic would be a coronavirus, not an influenza virus. With around 80 candidate vaccines reported to be in development, choosing the right one will be like playing roulette.These candidates will be whittled down as some will fail at an early stage of development and others will not get to scale-up for manufacturing. All of the world’s major vaccine pharmaceutical companies have said that they will divert resources to manufacture COVID-19 vaccines and, as long as they choose the right candidate for production, they have the expertise and the capacity to produce in huge quantities.From roulette to a horse raceOur game now changes from roulette to a horse race, as the probability of winning is a matter of odds not a random chance. Countries are now able to try to make contracts alone or in purchasing consortia with other states, and with one of the major companies or with multiple companies. This would be like betting on one of the favourites.For example, it has been reported that Oxford University has made an agreement with pharmaceutical company AstraZeneca, with a possibility of 100 million doses being available by the end of 2020. If the vaccine works and those doses materialize, and are all available for the UK, then the UK population requirements will be met in full, and the challenge becomes vaccinating everyone as quickly as possible.Even if half of the doses were reserved for the UK, all those in high-risk or occupational groups could be vaccinated rapidly. However, as each major manufacturer accepts more contracts, the quantity that each country will get diminishes and the time to vaccinate the at-risk population gets longer.At this point, it is not known how manufacturers will respond to requests for vaccine and how they will apportion supplies between different markets. You could bet on an outsider. You study the field and select a biotech that has potential with a good production development programme and a tie-in with a smaller-scale production facility.If other countries do not try to get contracts, you will get your vaccine as fast as manufacturing can be scaled up; but because it is a small manufacturer, your supplies may take a long time. And outsiders do not often win races. You can of course, depending on your resources, cover several runners and try to make multiple contracts. However, you take on the risk that some will fail, and you may have compromised your eventual supply.On April 24, the WHO co-hosted a meeting with the president of France, the president of the European Commission and the Bill & Melinda Gates Foundation. It brought together heads of state and industry leaders who committed to ‘work towards equitable global access based on an unprecedented level of partnership’. They agreed ‘to create a strong unified voice, to build on past experience and to be accountable to the world, to communities and to one another’ for vaccines, testing materials and treatments.They did not, however, say how this will be achieved and the absence of the United States was notable. The EU and its partners are hosting an international pledging conference on May 4 that aims to raise €7.5 billion in initial funding to kick-start global cooperation on vaccines. Co-hosts will be France, Germany, Italy, the United Kingdom, Norway and Saudi Arabia and the priorities will be ‘Test, Treat and Prevent’, with the latter dedicated to vaccines.Despite these expressions of altruism, every government will face the tension between wanting to protect their own populations as quickly as possible and knowing that this will disadvantage poorer countries, where health services are even less able to cope. It will not be a vote winner to offer a share in available vaccine to less-privileged countries.The factories for the biggest vaccine manufacturers are in Europe, the US and India. Will European manufacturers be obliged by the EU to restrict sales first to European countries? Will the US invoke its Defense Production Act and block vaccine exports until there are stocks enough for every American? And will vaccine only be available in India for those who can afford it?The lessons on vaccine availability from the 2009 influenza pandemic are clear: vaccine was not shared on anything like an equitable basis. It remains to be seen if we will do any better in 2020. Full Article
you 5 things you need to know to understand the Iran-US crisis By feedproxy.google.com Published On :: Wed, 15 Jan 2020 12:28:24 +0000 Source CNN URL https://edition.cnn.com/2020/01/08/middleeast/trump-qasem-soleimani-iran-us-iraq... Release date 08 January 2020 Expert Dr Leslie Vinjamuri In the news type Op-ed Hide date on homepage Full Article
you Getting Inside Your Head - The brain's communication pathways: Part 1 By www.ams.org Published On :: Wed, 18 Sep 2013 13:07:40 -0400 Van Wedeen talks about the geometry of the brain's communication pathways. Full Article
you When Your Passion Works Against You By www8.gsb.columbia.edu Published On :: Wed, 06 May 2020 17:02:52 +0000 Strategy Tuesday, April 28, 2020 - 13:00 Full Article
you So You Want To Save Humanity? Manage Nature Like A Business By www.forbes.com Published On :: Thu, 30 Apr 2020 00:00:00 GMT In the wake of the COVID-19 crisis, any economic stimulus measures must safeguard nature or governments risk exposing humanity to further pandemics. Full Article
you BongaCash: perfect conversions with your webcam traffic! By forums.digitalpoint.com Published On :: Fri, 08 May 2020 15:51:08 +0000 Full Article
you Where can I buy YouTube subscribers safely? By forums.digitalpoint.com Published On :: Sat, 09 May 2020 06:54:31 +0000 Full Article
you Your Slow Website is Killing Your Business- Level up with our affordable VPS server By forums.digitalpoint.com Published On :: Sat, 09 May 2020 09:28:51 +0000 Full Article
you What's Your Favorite Social Media Platform? By forums.digitalpoint.com Published On :: Sat, 09 May 2020 10:55:55 +0000 Full Article
you Which is your oldest website that you still own and is still online? By forums.digitalpoint.com Published On :: Sat, 09 May 2020 17:08:16 +0000 Full Article
you The Youth Guide to Biodiversity (1st edition), including a biosafety and agriculture part, is now available (page 122-123) By bch.cbd.int Published On :: Fri, 05 Apr 2013 00:00:00 GMT Full Article
you CBD News: The Executive Secretary of the Convention, Dr. Ahmed Djoghlaf, is pleased to invite you to the second CBD Linnaeus Lectures series highlighting major issues related to biological diversity - and our collective efforts to protect it worldwide. Sp By www.cbd.int Published On :: Tue, 20 May 2008 00:00:00 GMT Full Article
you CBD News: Message from Dr. Ahmed Djoghlaf, Executive Secretary of the Convention on Biological Diversity, on the occasion of International Youth Day, 12 August 2008. By www.cbd.int Published On :: Tue, 12 Aug 2008 00:00:00 GMT Full Article
you CBD News: Statement by Mr Ahmed Djoghlaf, Executive Secretary of the Convention on Biological Diversity, on the occasion of the 2nd International Youth Symposium for Biodiversity, 4 July 2009, Ottawa, Canada. By www.cbd.int Published On :: Sat, 04 Jul 2009 00:00:00 GMT Full Article
you CBD News: The Executive Secretary of the CBD invites you to participate in the peer review of the draft report of scientific synthesis on ocean acidification and its impacts on marine biodiversity and habitats. Please submit your comments and suggestions By www.cbd.int Published On :: Mon, 10 Aug 2009 00:00:00 GMT Full Article
you CBD News: Message from Ahmed Djoghlaf, Executive Secretary, on the occasion of International Youth Day, 12 August 2009. By www.cbd.int Published On :: Wed, 12 Aug 2009 00:00:00 GMT Full Article
you CBD Communiqué: Young Talent Recognised in Global Photography Competition. By www.cbd.int Published On :: Mon, 07 Dec 2009 00:00:00 GMT Full Article
you CBD Communiqué: President of Tunisia Gives a Voice to the Youth for Protecting Life on Earth and Their Future. By www.cbd.int Published On :: Fri, 11 Jun 2010 00:00:00 GMT Full Article
you CBD News: Statement by Mr Ahmed Djoghlaf, the Executive Secretary of the Convention On Biological Diversity, on the occasion of the European Youth Perspective Conference on Biodiversity, 2 July 2010, Geel, Belgium. By www.cbd.int Published On :: Fri, 02 Jul 2010 00:00:00 GMT Full Article
you CBD Communiqué: Engaging children and youth on biodiversity at the Farnborough International Airshow. By www.cbd.int Published On :: Fri, 23 Jul 2010 00:00:00 GMT Full Article
you CBD News: Message from Ahmed Djoghlaf, Executive Secretary of the Convention on Biological Diversity, on the Occasion of the International Youth Day, 12 August 2010. By www.cbd.int Published On :: Thu, 12 Aug 2010 00:00:00 GMT Full Article
you CBD Communiqué: Call for urgent action by the Aichi International Youth Conference on Biodiversity. By www.cbd.int Published On :: Tue, 07 Sep 2010 00:00:00 GMT Full Article
you CBD Communiqué: Winners announced: Young Hands Together for Diversity International Biodiversity Art Competition. By www.cbd.int Published On :: Wed, 06 Oct 2010 00:00:00 GMT Full Article
you CBD News: Statement of the CBD Executive Secretary, Braulio Ferreira de Souza Dias, on the occasion of World Environment Day - 5 June 2014: "Raise your voice, not the sea level" By www.cbd.int Published On :: Wed, 04 Jun 2014 00:00:00 GMT Full Article
you CBD News: The pilot programme is targeting young scholars who wish to gain experience by participating in the development of the regional and sub-regional assessments (Africa, Americas, Asia-Pacific and Europe and Central Asia) or the thematic assessment By www.ipbes.net Published On :: Wed, 06 May 2015 00:00:00 GMT Full Article
you CBD News: Young people between the ages of 10 and 24 comprise about 1.8 billion people, or about one quarter of the global population. This, according to the United Nations Population Fund, is the largest youth population ever. By www.cbd.int Published On :: Tue, 11 Aug 2015 00:00:00 GMT Full Article
you CBD News: It is my pleasure to welcome you to the nineteenth meeting of the Subsidiary Body on Scientific, Technical and Technological Advice and to welcome you all back to Montreal. It has been a year since we gathered in Pyeongchang, Republic of Korea, By www.cbd.int Published On :: Mon, 02 Nov 2015 00:00:00 GMT Full Article
you CBD News: Chairperson, Distinguished Delegates, Ladies and Gentlemen, It is a pleasure to address you at the 51st International Tropical Timber Council with good news late on a day you have spent in difficult negotiations. By www.cbd.int Published On :: Mon, 16 Nov 2015 00:00:00 GMT Full Article
you CBD News: It is a pleasure to join you here in Kuala Lumpur for the fourth session of the IPBES Plenary. We come together for a very exciting moment in the history of IPBES, when the Plenary will be presented with the first two assessments for its accepta By www.cbd.int Published On :: Mon, 22 Feb 2016 00:00:00 GMT Full Article
you CBD News: I am pleased to welcome you all to the eleventh meeting of the Liaison Group on Capacity-building for Biosafety here in Montreal. I wish to thank you all for taking time from your busy schedules to attend this meeting, which is expected to play By www.cbd.int Published On :: Mon, 14 Mar 2016 00:00:00 GMT Full Article
you CBD News: It is a great pleasure to welcome you to the city of Montreal, where the Great Lakes Waterway and the Saint Lawrence Seaway meet, on the occasion of the 6th GEF-UNDP-IMO Research and Development Forum and Exhibition on Ballast Water Management. By www.cbd.int Published On :: Wed, 16 Mar 2016 00:00:00 GMT Full Article
you CBD News: It gives me immense pleasure to extend a warm welcome to you all to this Capacity-building Workshop for Africa on achieving Aichi Biodiversity Targets 11 and 12. This workshop is the fourth in a series being organized by the CBD Secretariat in c By www.cbd.int Published On :: Mon, 21 Mar 2016 00:00:00 GMT Full Article
you CBD News: It is a great pleasure to welcome you all to Montreal for this inaugural meeting of the Compliance Committee under the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization. By www.cbd.int Published On :: Wed, 06 Apr 2016 00:00:00 GMT Full Article
you CBD News: It is my pleasure to welcome you all to this Technical Workshop on Monitoring of Marine and Coastal Biodiversity, being held on the margins of the twentieth meeting of the Subsidiary Body on Scientific, Technical and Technological Advice. By www.cbd.int Published On :: Sun, 24 Apr 2016 00:00:00 GMT Full Article
you CBD News: It is my pleasure to welcome you to the twentieth meeting of the Subsidiary Body on Scientific, Technical and Technological Advice and to welcome you all back to Montreal. By www.cbd.int Published On :: Mon, 25 Apr 2016 00:00:00 GMT Full Article
you CBD News: I am honoured to address the second committee of the UN General Assembly under your chairmanship. By www.cbd.int Published On :: Mon, 10 Oct 2016 00:00:00 GMT Full Article
